TriaGen Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
TriaGen Wealth Management's LLY Position: Q2 2026 in Review
TriaGen Wealth Management opened a new position in Eli Lilly (LLY) in Q2 2026: 244 shares worth $293K. The stake represents 0.07% of the portfolio and ranks #158 among its holdings. This is a return to the name: TriaGen Wealth Management previously reported a position in LLY as recently as Q4 2025.
TriaGen Wealth Management first reported a position in LLY in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.09M in Q3 2023. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TriaGen Wealth Management held 244 shares of Eli Lilly worth $293K as of Q2 2026.
- Eli Lilly was a new TriaGen Wealth Management position in Q2 2026.
- Eli Lilly made up 0.07% of TriaGen Wealth Management's portfolio in Q2 2026, its #158 holding.
- TriaGen Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 9 quarters since.
- TriaGen Wealth Management's Eli Lilly position peaked at $1.09M in Q3 2023.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.